{"id":"https://openalex.org/W4385476740","doi":"https://doi.org/10.1111/bph.16204","title":"Ticagrelor inverse agonist activity at the P2Y12 receptor is non\u2010reversible versus its endogenous agonist adenosine 5\u00b4\u2010diphosphate","display_name":"Ticagrelor inverse agonist activity at the P2Y12 receptor is non\u2010reversible versus its endogenous agonist adenosine 5\u00b4\u2010diphosphate","publication_year":2023,"publication_date":"2023-08-02","ids":{"openalex":"https://openalex.org/W4385476740","doi":"https://doi.org/10.1111/bph.16204","pmid":"https://pubmed.ncbi.nlm.nih.gov/37530222","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10953389"},"language":"en","primary_location":{"id":"doi:10.1111/bph.16204","doi":"https://doi.org/10.1111/bph.16204","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.16204","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16204","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16204","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023966525","display_name":"Jawad S. Khalil","orcid":"https://orcid.org/0000-0002-1408-9523","observed_orcids":["https://orcid.org/0000-0002-1408-9523"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jawad Khalil","raw_affiliation_strings":["School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tudor Dimofte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tudor Dimofte","raw_affiliation_strings":["School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Timothy Roberts","orcid":"https://orcid.org/0000-0002-6680-4816","observed_orcids":["https://orcid.org/0000-0002-6680-4816"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Timothy Roberts","raw_affiliation_strings":["School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK"],"raw_orcid":"https://orcid.org/0000-0002-6680-4816","affiliations":[{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073994859","display_name":"M. J. Keith","orcid":"https://orcid.org/0000-0001-5567-5492","observed_orcids":["https://orcid.org/0000-0001-5567-5492"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Keith","raw_affiliation_strings":["School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092786711","display_name":"Kumuthu S. Amaradasa","orcid":"https://orcid.org/0009-0000-9562-8420","observed_orcids":["https://orcid.org/0009-0000-9562-8420"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kumuthu Amaradasa","raw_affiliation_strings":["School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086615254","display_name":"Matthew S. Hindle","orcid":"https://orcid.org/0000-0002-5633-2034","observed_orcids":["https://orcid.org/0000-0002-5633-2034"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew S. Hindle","raw_affiliation_strings":["Leeds Institute of Genetics, Health and Therapeutics (LIGHT) University of Leeds Leeds UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute of Genetics, Health and Therapeutics (LIGHT) University of Leeds Leeds UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008774954","display_name":"Sukhinder Bancroft","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sukhinder Bancroft","raw_affiliation_strings":["School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038204177","display_name":"James L. Hutchinson","orcid":"https://orcid.org/0000-0001-6542-0151","observed_orcids":["https://orcid.org/0000-0001-6542-0151"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James L. Hutchinson","raw_affiliation_strings":["School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086090291","display_name":"Khalid M. Naseem","orcid":"https://orcid.org/0000-0002-3870-8747","observed_orcids":["https://orcid.org/0000-0002-3870-8747","https://orcid.org/0000-0002-8545-3871"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Khalid Naseem","raw_affiliation_strings":["Leeds Institute of Genetics, Health and Therapeutics (LIGHT) University of Leeds Leeds UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute of Genetics, Health and Therapeutics (LIGHT) University of Leeds Leeds UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101730457","display_name":"Tom Johnson","orcid":"https://orcid.org/0000-0003-4638-601X","observed_orcids":["https://orcid.org/0000-0003-4638-601X"]},"institutions":[{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas Johnson","raw_affiliation_strings":["Bristol Medical School University of Bristol  Bristol UK","Bristol Medical School, Level 7 Queen's Building Bristol Royal Infirmary, Bristol, BS2 8HW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Medical School University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"Bristol Medical School, Level 7 Queen's Building Bristol Royal Infirmary, Bristol, BS2 8HW","institution_ids":["https://openalex.org/I2802901496"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078592171","display_name":"Stuart J. Mundell","orcid":"https://orcid.org/0000-0001-7754-3271","observed_orcids":["https://orcid.org/0000-0001-7754-3271"]},"institutions":[{"id":"https://openalex.org/I36234482","display_name":"University of Bristol","ror":"https://ror.org/0524sp257","country_code":"GB","type":"education","lineage":["https://openalex.org/I36234482"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Stuart J. Mundell","raw_affiliation_strings":["School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK"],"raw_orcid":"https://orcid.org/0000-0001-7754-3271","affiliations":[{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences University of Bristol  Bristol UK","institution_ids":["https://openalex.org/I36234482"]},{"raw_affiliation_string":"School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, University of Bristol, BS8 1TD Bristol, UK","institution_ids":["https://openalex.org/I36234482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5078592171"],"corresponding_institution_ids":["https://openalex.org/I36234482"],"apc_list":{"value":4330,"currency":"USD","value_usd":4330},"apc_paid":{"value":4330,"currency":"USD","value_usd":4330},"fwci":1.8545,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.87382635,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"181","issue":"1","first_page":"21","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.0934000015258789,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.024700000882148743,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ticagrelor","display_name":"ticagrelor","score":1.0},{"id":"https://openalex.org/keywords/p2y12-receptor","display_name":"P2Y12 receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adp","display_name":"ADP","score":0.7390000224113464},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/g-protein-activation","display_name":"G protein activation","score":0.6380000114440918},{"id":"https://openalex.org/keywords/orthosteric-binding-pocket","display_name":"orthosteric binding pocket","score":0.8420000076293945},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.8569999933242798},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.6069999933242798},{"id":"https://openalex.org/keywords/platelet-transfusion","display_name":"platelet transfusion","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C2780890252","wikidata":"https://www.wikidata.org/wiki/Q420542","display_name":"Ticagrelor","level":4,"score":0.9874469041824341},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7009817957878113},{"id":"https://openalex.org/C49059817","wikidata":"https://www.wikidata.org/wiki/Q14916330","display_name":"P2Y12","level":4,"score":0.6931963562965393},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5529711246490479},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.5253812074661255},{"id":"https://openalex.org/C3018697912","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Platelet activation","level":3,"score":0.5249317288398743},{"id":"https://openalex.org/C160225129","wikidata":"https://www.wikidata.org/wiki/Q6591687","display_name":"P2Y receptor","level":4,"score":0.49439072608947754},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.49330630898475647},{"id":"https://openalex.org/C2777399203","wikidata":"https://www.wikidata.org/wiki/Q185253","display_name":"Adenosine diphosphate","level":4,"score":0.4924367368221283},{"id":"https://openalex.org/C89951826","wikidata":"https://www.wikidata.org/wiki/Q1671731","display_name":"Inverse agonist","level":4,"score":0.482272207736969},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43523144721984863},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.431432843208313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42159321904182434},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3624529242515564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25621360540390015},{"id":"https://openalex.org/C2993802102","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet aggregation","level":3,"score":0.20499902963638306},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.1958315670490265},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.1184769868850708}],"mesh":[{"descriptor_ui":"D000077486","descriptor_name":"Ticagrelor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000077486","descriptor_name":"Ticagrelor","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077486","descriptor_name":"Ticagrelor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000244","descriptor_name":"Adenosine Diphosphate","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000244","descriptor_name":"Adenosine Diphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000244","descriptor_name":"Adenosine Diphosphate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011756","descriptor_name":"Diphosphates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011756","descriptor_name":"Diphosphates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011756","descriptor_name":"Diphosphates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054314","descriptor_name":"Drug Inverse Agonism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058921","descriptor_name":"Purinergic P2Y Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D058925","descriptor_name":"Receptors, Purinergic P2Y12","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1111/bph.16204","doi":"https://doi.org/10.1111/bph.16204","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.16204","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16204","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"doi:10.22541/au.165650402.25770089/v1","doi":"https://doi.org/10.22541/au.165650402.25770089/v1","is_oa":true,"landing_page_url":"https://doi.org/10.22541/au.165650402.25770089/v1","pdf_url":"https://www.authorea.com/doi/pdf/10.22541/au.165650402.25770089","source":null,"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:10953389","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10953389","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10953389/pdf/BPH-181-21.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:37530222","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37530222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire/806a7433-427e-46a4-9ec4-1db6e4eb2895","doi":null,"is_oa":true,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/806a7433-427e-46a4-9ec4-1db6e4eb2895","pdf_url":null,"source":{"id":"https://openalex.org/S4306400895","display_name":"Bristol Research (University of Bristol)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I36234482","host_organization_name":"University of Bristol","host_organization_lineage":["https://openalex.org/I36234482"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Khalil, J, Dimofte, T, Roberts, T, Keith, M, Amaradasa, K, Hindle, M S, Bancroft, S, Hutchinson, J L, Naseem, K, Johnson, T & Mundell, S J 2024, 'Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist adenosine 5\u00b4-diphosphate', British Journal of Pharmacology, vol. 181, no. 1, pp. 21-35. https://doi.org/10.1111/bph.16204","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire_cris_publications/806a7433-427e-46a4-9ec4-1db6e4eb2895","doi":null,"is_oa":true,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/806a7433-427e-46a4-9ec4-1db6e4eb2895","pdf_url":null,"source":{"id":"https://openalex.org/S7407055359","display_name":"Explore Bristol Research","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Khalil, J, Dimofte, T, Roberts, T, Keith, M, Amaradasa, K, Hindle, M S, Bancroft, S, Hutchinson, J L, Naseem, K, Johnson, T & Mundell, S J 2024, 'Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist adenosine 5\u00b4-diphosphate', British Journal of Pharmacology, vol. 181, no. 1, pp. 21-35. https://doi.org/10.1111/bph.16204","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.leedsbeckett.ac.uk:10000","doi":null,"is_oa":true,"landing_page_url":"https://eprints.leedsbeckett.ac.uk/view/creators/Khalil=3AJ=3A=3A.html>","pdf_url":"https://eprints.leedsbeckett.ac.uk/id/eprint/10000/2/TicagrelorInverseAgonistActivityAtTheP2Y12ReceptorIsNonreversibleVersusItsEndogenousAgonistAdpPV-HINDLE.pdf","source":{"id":"https://openalex.org/S4306400805","display_name":"Leeds Beckett Repository (Leeds Beckett University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84027002","host_organization_name":"Leeds Beckett University","host_organization_lineage":["https://openalex.org/I84027002"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/bph.16204","doi":"https://doi.org/10.1111/bph.16204","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bph.16204","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16204","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3451288380","display_name":"Regulation of TP thromboxane receptor expression and activity by selective P2Y12 receptor antagonists in human platelets: consequences for dual antiplatelet therapy?","funder_award_id":"PG/20/1/34617","funder_id":"https://openalex.org/F4320319992","funder_display_name":"British Heart Foundation"},{"id":"https://openalex.org/G5732488411","display_name":"Regulation of P2Y12 receptor expression and activity by inhibitory pathways in human platelets: a novel mode of action of antiplatelet drugs?","funder_award_id":"PG/17/62/33190","funder_id":"https://openalex.org/F4320319992","funder_display_name":"British Heart Foundation"}],"funders":[{"id":"https://openalex.org/F4320319992","display_name":"British Heart Foundation","ror":"https://ror.org/02wdwnk04"},{"id":"https://openalex.org/F4320320154","display_name":"British Pharmacological Society","ror":"https://ror.org/02bmd7x67"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385476740.pdf","grobid_xml":"https://content.openalex.org/works/W4385476740.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W175926515","https://openalex.org/W982389493","https://openalex.org/W1484512772","https://openalex.org/W1877581810","https://openalex.org/W1982519656","https://openalex.org/W1996554118","https://openalex.org/W2014673121","https://openalex.org/W2023649595","https://openalex.org/W2063213732","https://openalex.org/W2066475453","https://openalex.org/W2066521300","https://openalex.org/W2069561061","https://openalex.org/W2087951913","https://openalex.org/W2095100698","https://openalex.org/W2140501627","https://openalex.org/W2141358924","https://openalex.org/W2150934225","https://openalex.org/W2161055506","https://openalex.org/W2165955919","https://openalex.org/W2169387542","https://openalex.org/W2170260872","https://openalex.org/W2524830748","https://openalex.org/W2571580731","https://openalex.org/W2659327378","https://openalex.org/W2808013409","https://openalex.org/W2866906490","https://openalex.org/W2900272649","https://openalex.org/W2917818298","https://openalex.org/W2920794399","https://openalex.org/W2921627848","https://openalex.org/W2967836975","https://openalex.org/W2970624546","https://openalex.org/W3142121480","https://openalex.org/W3145711964","https://openalex.org/W3162195278","https://openalex.org/W3199710005","https://openalex.org/W4282941439"],"related_works":["https://openalex.org/W4293250902","https://openalex.org/W2069561061","https://openalex.org/W2024656127","https://openalex.org/W2981362354","https://openalex.org/W2066521300","https://openalex.org/W1982513890","https://openalex.org/W1971933594","https://openalex.org/W7025040490","https://openalex.org/W7100550942","https://openalex.org/W4295215042"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"and":[2,81,132,168,186,194,228],"Purpose":[3],"Ticagrelor":[4,188],"is":[5,17,192],"labelled":[6],"as":[7],"a":[8,109],"reversible,":[9],"direct\u2010acting":[10],"platelet":[11,48,82,131],"P2Y12":[12],"receptor":[13],"(P2Y12R)":[14],"antagonist":[15],"that":[16,108,166,198],"indicated":[18],"clinically":[19],"for":[20,217,229],"the":[21,62,67,174,179,205,213],"prevention":[22],"of":[23,55,64,100,111,141,178,199],"thrombotic":[24],"events":[25],"in":[26,43,50,74,129,222],"patients":[27,223],"with":[28,34,77,160,224,232],"acute":[29],"coronary":[30],"syndrome":[31],"(ACS).":[32],"As":[33],"many":[35],"antiplatelet":[36],"drugs,":[37],"ticagrelor":[38,65,123,167,219],"therapy":[39],"increases":[40],"bleeding":[41,230],"risk":[42],"patients,":[44],"which":[45,149],"may":[46],"require":[47],"transfusion":[49],"emergency":[51],"situations.":[52],"The":[53,145],"aim":[54],"this":[56],"study":[57,211],"was":[58,124,150,155],"to":[59,94,126,137,153,157,190,197],"further":[60],"examine":[61],"reversibility":[63],"at":[66,120],"P2Y12R.":[68,121],"Experimental":[69],"Approach":[70],"Studies":[71],"were":[72,92],"performed":[73],"human":[75,130],"platelets,":[76],"P2Y12R\u2010stimulated":[78],"GTPase":[79],"activity":[80,119],"aggregation":[83],"assessed.":[84],"Cell\u2010based":[85],"bioluminescence":[86],"resonance":[87],"energy":[88],"transfer":[89],"(BRET)":[90],"assays":[91],"undertaken":[93],"assess":[95],"G":[96],"protein\u2010subunit":[97],"activation":[98],"downstream":[99],"P2Y12R":[101,112,143,146,180,183,191,207],"activation.":[102],"Key":[103],"Results":[104],"Initial":[105],"studies":[106],"revealed":[107,165],"range":[110],"ligands,":[113],"including":[114],"ticagrelor,":[115],"displayed":[116],"inverse":[117],"agonist":[118,147,208],"Only":[122],"resistant":[125,152],"washout":[127],"and,":[128],"cell\u2010based":[133],"assays,":[134],"washing":[135],"failed":[136],"reverse":[138],"ticagrelor\u2010dependent":[139],"inhibition":[140],"ADP\u2010stimulated":[142],"function.":[144],"2MeSADP,":[148],"also":[151],"washout,":[154],"able":[156],"effectively":[158],"compete":[159],"ticagrelor.":[161],"In":[162],"silico":[163],"docking":[164],"2MeSADP":[169],"penetrated":[170],"more":[171,195],"deeply":[172],"into":[173],"orthosteric":[175],"binding":[176,189],"pocket":[177],"than":[181],"other":[182],"ligands.":[184],"Conclusion":[185],"Implications":[187],"prolonged":[193],"akin":[196],"an":[200],"irreversible":[201],"antagonist,":[202],"especially":[203],"versus":[204],"endogenous":[206],"ADP.":[209],"This":[210],"highlights":[212],"potential":[214],"clinical":[215],"need":[216],"novel":[218],"reversal":[220],"strategies":[221],"spontaneous":[225],"major":[226],"bleeding,":[227],"associated":[231],"urgent":[233],"invasive":[234],"procedures.":[235]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-08-03T00:00:00"}